These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


686 related items for PubMed ID: 22547422

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan.
    Yoshihara A, Noh JY, Watanabe N, Mukasa K, Ohye H, Suzuki M, Matsumoto M, Kunii Y, Suzuki N, Kameda T, Iwaku K, Kobayashi S, Sugino K, Ito K.
    Thyroid; 2015 Oct; 25(10):1155-61. PubMed ID: 26222916
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Treatment of hyperthyroidism due to Graves' disease: what is the recommended antithyroid drug during pregnancy?].
    Caron P.
    J Gynecol Obstet Biol Reprod (Paris); 2013 May; 42(3):232-7. PubMed ID: 23312275
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study.
    Chen CH, Xirasagar S, Lin CC, Wang LH, Kou YR, Lin HC.
    BJOG; 2011 Oct; 118(11):1365-73. PubMed ID: 21624036
    [Abstract] [Full Text] [Related]

  • 8. Treatment of hyperthyroidism in pregnancy and birth defects.
    Clementi M, Di Gianantonio E, Cassina M, Leoncini E, Botto LD, Mastroiacovo P, SAFE-Med Study Group.
    J Clin Endocrinol Metab; 2010 Nov; 95(11):E337-41. PubMed ID: 20668039
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Antithyroid agents and embryopathies].
    Bournaud C, Orgiazzi J.
    Ann Endocrinol (Paris); 2003 Nov; 64(5 Pt 1):366-9. PubMed ID: 15067747
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT, Hsieh AT, Pei D, Hung YJ, Wu LY, Yang TC, Lian WC, Huang WS, Kuo SW.
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [Abstract] [Full Text] [Related]

  • 13. Antithyroid Drugs and Congenital Malformations: A Nationwide Korean Cohort Study.
    Seo GH, Kim TH, Chung JH.
    Ann Intern Med; 2018 Mar 20; 168(6):405-413. PubMed ID: 29357398
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Pregnancy outcomes of exposure to methimazole (POEM) study].
    Arata N.
    Nihon Rinsho; 2012 Nov 20; 70(11):1976-82. PubMed ID: 23214071
    [Abstract] [Full Text] [Related]

  • 16. The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant.
    Kimura M, Seki T, Ozawa H, Ishihara T, Komatsu M, Tajiri S, Yanagi H, Nishina M, Noh JY, Fukagawa M, Takagi A.
    Endocr J; 2013 Nov 20; 60(3):383-8. PubMed ID: 23154533
    [Abstract] [Full Text] [Related]

  • 17. Treatment of Graves' hyperthyroidism with thionamides: a position paper on indications and safety in pregnancy.
    Tonacchera M, Chiovato L, Bartalena L, Cavaliere AF, Vitti P.
    J Endocrinol Invest; 2020 Feb 20; 43(2):257-265. PubMed ID: 31784912
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Antithyroid drug therapy in pregnancy and risk of congenital anomalies: Systematic review and meta-analysis.
    Agrawal M, Lewis S, Premawardhana L, Dayan CM, Taylor PN, Okosieme OE.
    Clin Endocrinol (Oxf); 2022 Jun 20; 96(6):857-868. PubMed ID: 34845757
    [Abstract] [Full Text] [Related]

  • 20. Teratogen update: Antithyroid medications.
    Romeo AN, Običan SG.
    Birth Defects Res; 2020 Sep 20; 112(15):1150-1170. PubMed ID: 32738035
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 35.